What are the treatment protocols for reducing ketonemia in patients with diabetic ketoacidosis?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18206294
Cited by: 0

Abstract

Early subcutaneous insulin, used alongside intravenous insulin, can effectively reduce ketonemia and resolve DKA more rapidly without significant safety concerns.

Fields of Study & Subjects

Diabetes Management and Research Hyperglycemia and glycemic control in critically ill and hospitalized patients Diabetes Treatment and Management

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
10 January 2026